As I’ve said several times, I’m not a physician, so my opinion on these matters is only that of someone who has undergone the same fears, tests, and outcomes as many of you. Nonetheless, now that I’ve written a book, friends call me about their prostate problems, and I try to answer as best I can.
This month was strange, because I got two... Read more
The other night, Memorial Sloan-Kettering Cancer Center held a Survivor’s Day. It’s billed as the National Survivor’s Day, but I’m not sure how wide-spread the attendees are. There were about 200 survivors in the large auditorium, and about 20 staff, more or less. I was asked to speak, as was Harry Smith, anchor of CBS’s The Early... Read more
Most people who get a disease, especially cancer, will want to do something about it. If that’s your decision, you still have choices: surgery, radiation, seed implantation, and hormones. What follows is from the May 29th issue of Business Week:
Even today, with a high-tech health-care system that costs the nation $2 trillion a year, there is... Read more
A couple of weeks ago, I started to talk about the idea that doing “nothing” or next to nothing about your prostate cancer might be a worthwhile plan of action. Some people may think this is a dangerous, if not anti-medical, approach.
In the interim, an article in the New York Times approached the subject from a different perspective, and I... Read more
In a recent article by HealthDay News, E.J. Mundell, a HealthDay reporter, points to a number of issues that have severely reduced the volunteers available for clinical trials in a variety of cancers.
Because this is an important aspect of care for some cancer patients, I wanted to comment on the article, the problems and the opportunities.
First... Read more